Risk factors for Barrett's esophagus compared between African Americans and non-hispanic whites

American Journal of Gastroenterology

Volumn 109, Issue 12, 2014, Pages 1870-1880

  Nguyen, Theresa H ^a   Thrift, Aaron P ^b   Ramsey, David ^a   Green, Linda ^b,c   Shaib, Yasser H ^b   Graham, David Y ^b   El Serag, Hashem B ^a,b  

^a VA HSR and D Houston Center of Excellence   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR;

ADULT; AFRICAN AMERICAN; ARTICLE; BARRETT ESOPHAGUS; CASE CONTROL STUDY; CAUCASIAN; CHRONIC GASTRITIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DRUG USE; DYSPLASIA; ESOPHAGOGASTRODUODENOSCOPY; ESOPHAGUS DYSPLASIA; FEMALE; GASTROESOPHAGEAL REFLUX; HELICOBACTER INFECTION; HIATUS HERNIA; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PREVALENCE; PRIORITY JOURNAL; RACE DIFFERENCE; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SMOKING; VETERAN; WAIST HIP RATIO; AGED; DIGESTIVE TRACT ENDOSCOPY; ETHNOLOGY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HERNIA, HIATAL; MIDDLE AGED; OVERWEIGHT; PATHOLOGY; PRECANCEROUS CONDITIONS; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; UNITED STATES; VERY ELDERLY;

ADULT; AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; BARRETT ESOPHAGUS; ENDOSCOPY, DIGESTIVE SYSTEM; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GASTROESOPHAGEAL REFLUX; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HERNIA, HIATAL; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; OVERWEIGHT; PRECANCEROUS CONDITIONS; PROTON PUMP INHIBITORS; RISK FACTORS; SEX FACTORS; SMOKING; UNITED STATES; VETERANS; WAIST-HIP RATIO;

EID: 84925223189     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2014.351     Document Type: Article

References (39)

1. Pera M. Trends in incidence and prevalence of specialized intestinal metaplasia, Barrett's esophagus, and adenocarcinoma of the gastroesophageal junction. World J Surg 2003; 27: 999-1008.
2. Jemal A, Bray F, Center M et al. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
3. Cook MB, Chow W-H, Devesa SS. Oesophageal cancer incidence in the United States by race, sex, and histologic type, 1977-2005. Br J Cancer 2009; 101: 855-9.
4. Thrift AP, Whiteman DC. The incidence of esophageal adenocarcinoma continues to rise: analysis of period and birth cohort effects on recent trends. Ann Oncol 2012; 23: 3155-62.
5. Kendall BJ, Whiteman DC. Temporal changes in the endoscopic frequency of new cases of Barrett's esophagus in an Australian health region. Am J Gastroenterol 2006; 101: 1178-82.
6. Younes M, Henson DE, Ertan A et al. Incidence and survival trends of esophageal carcinoma in the United States: racial and gender differences by histological type. Scand J Gastroenterol 2002; 37: 1359-65.
7. Baquet CR, Commiskey P, Mack K et al. Esophageal cancer epidemiology in blacks and whites: racial and gender disparities in incidence, mortality, survival rates and histology. J Natl Med Assoc 2005; 97: 1471-8.
8. Lieberman D, Fennerty MB, Morris CD et al. Endoscopic evaluation of patients with dyspepsia: results from the national endoscopic data repository. Gastroenterology 2004; 127: 1067-75.
9. Abrams JA, Fields S, Lightdale CJ et al. Racial and ethnic disparities in the prevalence of Barrett's esophagus among patients who undergo upper endoscopy. Clin Gastro and Hep 2008; 6: 30-4.
10. Wang A, Mattek NC, Holub JL et al. Prevalence of complicated gastroesophageal reflux disease and Barrett's esophagus among racial groups in a multi-center consortium. Dig Dis Sci 2009; 54: 964-71.
11. Corley DA, Kubo A, Levin TR et al. Race, ethnicity, sex and temporal differences in Barrett's oesophagus diagnosis: a large community-based study, 1994-2006. Gut 2009; 58: 182-8.
12. Fan X, Snyder N. Prevalence of Barrett's esophagus in patients withor without GERD symptoms: role of race, age, and gender. Dig Dis Sci 2009; 54: 572-7.
13. Ford AC, Forman D, Reynolds PD et al. Ethnicity, gender, and socioeconomic status as risk factors for esophagitis and Barrett's esophagus. Am J Epidemiol 2005; 162: 454-60.
14. El-Serag HB, Petersen NJ, Carter J. Gastroesophageal reflux among different racial groups in the United States. Gastroenterology 2004; 126: 1692-9.
15. Vega KJ, Chisholm S, Mazen Jamal M. Comparison of reflux esophagitis and its complications between African Americans and non-Hispanic whites. World J Gastroenterol 2009; 15: 2878-81.
16. Khoury JE, Chisholm S, Mazen Jamal M et al. African Americans with Barrett's esophagus are less likely to have dysplasia at biopsy. Dig Dis Sci 2012; 57: 419-23.
17. Khalaf N, Nguyen T, Ramsey D et al. Non-steroidal anti-inflammatory drugs and the risk of Barrett's esophagus. Clin Gastroenterol Hepatol; advance online publication, 30 April 2014; doi: 10.1016/j.cgh.2014.04.027 (e-pub ahead of print).
18. Kramer JR, Fischbach LA, Richardson P et al. Waist to hip ratio but not body mass index is associated with increased risk of Barrett's esophagus in white men. Clin Gastroenterol Hepatol 2013; 11: 373-81e1.
19. Sharma P, Dent J, Armstrong D et al. The development and validation of an endoscopic grading system for Barrett's esophagus: the Prague C & M criteria. Gastroenterology 2006; 131: 1392-9.
20. Rugge M, Meggio A, Pennelli G et al. Gastritis staging in clinical practice: the OLGA staging system. Gut 2007; 56: 631-66.
21. Dixon MF, Genta RM, Yardley JH et al. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of gastritis, Houston 1994. Am J Surg Pathol 1996; 20: 1161-81.
22. Ilanne-Parikka P, Eriksson JG, Lindstrom J et al. Prevalence of the metabolic syndrome and its components: fi ndings from a Finnish general population sample and the Diabetes Prevention Study cohort. Diabetes Care 2004; 27: 2135-40.
23. Locke GR, Talley NJ, Weaver Al et al. A new questionnaire for gastroesophageal reflux disease. Mayo Clin Proc 1991; 69: 539-47.
24. Concato J, Feinstein AR, Holford TR. The risk of determining risk with multivariable models. Ann Intern Med. 1993; 118: 201-10.
25. Corley DA, Kubo A, Zhao W. Abdominal obesity, ethnicity and gastrooesophageal reflux symptoms. Gut 2007; 56: 756-62.
26. Fischbach LA, Nordenstedt H, Kramer JR et al. The association between Barrett's esophagus and Helicobacter pylori infection: a meta-analysis. Helicobacter 2012; 17: 163-75.
27. Corley DA, Kubo A, Levin TR et al. Helicobacter pylori infection and the risk of Barrett's oesophagus: a community-based study. Gut 2008; 57: 727-33.
28. El-Serag HB, Sonnenberg A, Jamal MM et al. Characteristics of intestinal metaplasia in the gastric cardia. Am J Gastroenterol 1999; 94: 622-7.
29. Hirota WK, Loughney TM, Lazas DJ et al. Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esohagogastric junction: prevalence and clinical data. Gastroenterology 1999; 116: 277-85.
30. Lam KD, Phan JT, Garcia Rt et al. Low proportion of Barrett's esophagus in Asian Americans. Am J Gastroenterol 2008; 103: 1625-30.
31. Rex DK, Cummings OW, Shaw M et al. Screening for Barrett's esophagus in colonoscopy patients with and without heartburn. Gastroenterology 2003; 125: 1670-7.
32. Vicari JJ, Peek RM, Falk GW et al. The seroprevalence of cagA-positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease. Gastroenterology 1998; 115: 50-7.
33. Goldblum JR, Richter JE, Vaezi M et al. Helicobacter pylori infection, not gastroesophageal reflux, is the major cause of inflammation and intestinal metaplasia of gastric cardia mucosa. Am J Gastroenterol 2006; 97: 302-11.
34. Weston AP, Badr AS, Topalovski M et al. Prospective evaluation of the prevalence of gastric Helicobacter pylori infection in patients with GERD, Barrett's esophagus, Barrett's dysplasia, and Barrett's adenocarcinoma. Am J Gastroenterol 2000; 95: 387-94.
35. Paull G, Yardley JH. Gastric and esophageal Campylobacter pylori in patients with Barrett's esophagus. Gastroenterology 1988; 95: 216-8.
36. Sonnenberg A, Lash R, Genta R. A national study of Helicobacter pylori infection in gastric biopsy specimens. Gastroenterology 2010; 139: 1894-901.
37. Cook MB, Wood SN, Cash BD et al. Association between circulating levels of sex steroid hormones and Barrett's esophagus in men: a case-control analysis. Clin Gastroenterol Hepatol; advance online publication, 24 August 2014; doi: 10.1016/j.cgh.2014.08.027 (e-pub ahead of print).
38. Verbeek RE, Spittuler LF, Peute A et al. Familial clustering of Barrett's esophagus and esophageal adenocarcinoma in a European cohort. Clin Gastroenterol Hepatol; advance online publication, October 2014; doi: 10.1016/j.cgh.2014.01.028 (e-pub ahead of print).
39. Thrift AP, Risch HA, Onstad L et al. Risk of esophageal adenocarcinoma decreases with height, based on consortium analysis and confi rmed by mendelian randomization. Clin Gastroenterol Hepatol; advance online publication, February 2014; doi: 10.1016/j.cgh.2014.01.039 (e-pub ahead of print).